78 related articles for article (PubMed ID: 1731040)
21. NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Mar; 470():1-330. PubMed ID: 12579203
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
24. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
Hefti F; Gerold M; Holck M
J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
[TBL] [Abstract][Full Text] [Related]
25. Calcium entry-blockade with verapamil in cyclosporine A plus ischemia induced acute renal failure in rats.
Iaina A; Herzog D; Cohen D; Gavendo S; Kapuler S; Serban I; Schiby G; Eliahou HE
Clin Nephrol; 1986; 25 Suppl 1():S168-70. PubMed ID: 3708928
[TBL] [Abstract][Full Text] [Related]
26. Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys.
Kobayashi S; Hishida A
J Lab Clin Med; 1995 May; 125(5):572-80. PubMed ID: 7738423
[TBL] [Abstract][Full Text] [Related]
27. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet.
Kanno Y; Suzuki H; Okada H; Saruta T
J Cardiovasc Pharmacol; 1994 Mar; 23(3):480-4. PubMed ID: 7515994
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of t -Butyl Alcohol (CAS No. 75-65-0) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 436():1-305. PubMed ID: 12595927
[TBL] [Abstract][Full Text] [Related]
29. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
31. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
[TBL] [Abstract][Full Text] [Related]
32. Effects of anipamil on cardiovascular status and regional blood flow in anaesthetized rats.
Tabrizchi R; Pang CC; Walker MJ
Br J Pharmacol; 1989 Dec; 98(4):1185-90. PubMed ID: 2611488
[TBL] [Abstract][Full Text] [Related]
33. Effects of anipamil on electrocardiogram, plasma creatine kinase, and reperfusion arrhythmias after coronary occlusion in closed-chest rats.
Kirchengast M; Raschack M
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S73-5. PubMed ID: 2475696
[TBL] [Abstract][Full Text] [Related]
34. The Ca2+ -antagonist and binding properties of the phenylalkylamine, anipamil.
Dillon JS; Nayler WG
Br J Pharmacol; 1988 May; 94(1):253-63. PubMed ID: 2456811
[TBL] [Abstract][Full Text] [Related]
35. Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.
Raddino R; Poli E; Pasini E; Ferrari R
Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):339-44. PubMed ID: 1383837
[TBL] [Abstract][Full Text] [Related]
36. Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia.
Pugsley MK; Ries CR; Guppy LJ; Harvie CJ; Walker MJ
Life Sci; 1995; 57(12):1219-31. PubMed ID: 7674811
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive, anticalcinotic, and antiarteriosclerotic properties of anipamil, a long-acting new derivative of verapamil.
Frey M; Zorn J; Fleckenstein-Grün G; Fleckenstein A
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S23-8. PubMed ID: 2475679
[TBL] [Abstract][Full Text] [Related]
38. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.
Curtis MJ; Walker MJ; Yuswack T
Br J Pharmacol; 1986 Jun; 88(2):355-61. PubMed ID: 3755364
[TBL] [Abstract][Full Text] [Related]
39. The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.
MacLeod BA; Moult M; Saint KM; Walker MJ
Br J Pharmacol; 1989 Dec; 98(4):1165-72. PubMed ID: 2611487
[TBL] [Abstract][Full Text] [Related]
40. (-)-anipamil retards atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Hansen BF; Mortensen A; Hansen JF; Frandsen H
J Cardiovasc Pharmacol; 1995 Sep; 26(3):485-9. PubMed ID: 8583792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
